New drug could free kids from daily IV feeding
NCT ID NCT03562130
First seen Sep 30, 2025 · Last updated May 23, 2026 · Updated 35 times
Summary
This study tested a drug called Revestive® in 25 children aged 2 to 18 with short bowel syndrome who depend on IV nutrition at home. The goal was to see if the drug could help their intestines absorb more nutrients and reduce the need for IV feeding. Researchers measured changes in IV nutrition needs, stool output, and quality of life over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Necker - Enfants malades
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.